AstraZeneca, a global, science-based biopharmaceutical company, will invest $2 billion in Maryland to expand manufacturing, according to Governor Wes Moore.

The investment will include development of an AstraZeneca manufacturing facility in Frederick, along with a new state-of-the-art clinical manufacturing facility in Gaithersburg.

Governor Moore said the investment will support 2,600 jobs.

"AstraZeneca's significant investment and expansion in Maryland underscores our state's global leadership in life sciences and biomanufacturing," Moore said. "This landmark investment strengthens the U.S. medicine supply chain and accelerates the development of life-saving therapies, while creating hundreds of good-paying jobs for Marylanders. We are proud to partner with AstraZeneca to grow our eco

See Full Page